Hyung Heon Kim

Insider Reports History

Entity
Individual
Location
C/O Dong A St & Dong A Socio Group, 64 Cheonho Daero, Dongdaemun Gu, Seoul, Korea, Republic of
Signature
/s/ Phillip D. Torrence, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hyung Heon Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NeuroBo Pharmaceuticals, Inc. CEO & President, Director Common Stock 63.8K $163K $2.55 Nov 30, 2024 Direct

Insider Reports Filed by Hyung Heon Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MTVA MetaVia Inc. Nov 30, 2024 1 -$7.31K 4 Dec 2, 2024 CEO & President, Director
NRBO NeuroBo Pharmaceuticals, Inc. Aug 11, 2024 1 -$41.3K 4 Aug 13, 2024 CEO & President, Director
NRBO NeuroBo Pharmaceuticals, Inc. Aug 11, 2023 1 $0 4 Aug 14, 2023 CEO & President, Director
NRBO NeuroBo Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
NRBO NeuroBo Pharmaceuticals, Inc. Jul 9, 2021 0 $0 3 Jul 19, 2021 Director